In our small cohort, both groups had overall similar cytokine level patterns associated with elevations of IL-2, IL-6, IL-15, IFN-Υ, TNF-α, and Ang-2/Ang-1 ratio before any therapeutic interventions for ICANS or CRS. The gene discussed is IL2; the disease is congenital rubella syndrome.